Early diagnosis is critical in the management of patients with acute coronary syndrome (ACS), particularly ST-elevation myocardial infarction (STEMI), because effective therapies are time-dependent. Aims of this secondary analysis were to determine: (i) the prognostic value of symptoms for an ACS diagnosis in conjunction with electrocardiographic (ECG) and troponin results; and (ii) if any of 13 symptoms were associated with prehospital delay in those presenting to the emergency department (ED) with potential ACS. Patients receiving a cardiac evaluation in the ED were eligible for the study. Thirteen patient-reported symptoms were assessed in triage. Prehospital delay time was calculated as the time from symptom onset until registration in the ED.
(UA). The two primary approaches for optimizing ACS patient outcomes are to reduce treatment delay and to minimize total ischemic time, defined as time of symptom onset to reperfusion of culprit arteries (Hicks et al., 2015; O'Gara et al., 2013) . ACS symptoms trigger patient care seeking behaviors and inform providers' choice of diagnostic testing; yet symptoms are often ambiguous (Rosenfeld et al., 2015) . If symptoms are neither identified nor recognized, patients may be at risk for increased prehospital delay, delayed diagnosis, and increased mortality and morbidity (Doggen et al., 2016; Fanaroff, Rymer, Goldstein, Simel, & Newby, 2015; Menees et al., 2013; O'Gara et al., 2013; Wu, Moser, Riegel, McKinley, & Doering, 2011) .
Accurate risk stratification and diagnostic testing are critical for time dependent therapies that restore blood flow to the compromised myocardium, thereby reducing morbidity and mortality and avoiding inappropriate hospital discharge (Hess et al., 2015; Pelter, 2010) . To minimize total ischemic burden time, the American Heart Association and European Society of Cardiology (AHA/ESC) recommend that individuals with chest pain seek medical attention immediately and receive a 12-lead electrocardiogram (ECG) within 10 min of hospital arrival, based on evidence that longer delays are associated with adverse prognoses (O'Gara et al., 2013) . ECG results should be analyzed in conjunction with patient history and clinical presentation to assess the likelihood of an ACS diagnosis (O'Gara et al., 2013; Savonitto et al., 1999) .
ACS remains a diagnostic challenge because no single risk stratification model (e.g., Thrombolysis in Myocardial Infarction
[TIMI] risk score; history, ECG, age, risk factors, Troponin [HEART] score) or diagnostic strategy has been shown to identify all ACS cases accurately and there is no clear reference standard (Cullen et al., 2013; Fanaroff et al., 2015; Worrall-Carter et al., 2015) . Findings from prior studies suggest that patients presenting with chest symptoms (chest pain, chest pressure, or chest discomfort) have a high likelihood of an ACS diagnosis and certain clinical features (e.g., pulmonary basal crackles, hypotension) can predict ACS, but neither alone can confirm an ACS diagnosis (Body et al., 2010; DeVon, Rosenfeld, Steffen, & Daya, 2014) . Little is known about the association between non-chest symptoms reported by patients in the ED, while they are occurring, with ECG and other clinical characteristics. The purpose of this study was to determine (i) the prognostic value of symptoms for an ACS diagnosis in conjunction with electrocardiographic (ECG) and troponin results; and (ii) if any of 13 symptoms were associated with prehospital delay in those presenting to the ED with potential ACS. These aims are important to better characterize the early presentation of ACS for improved triage, risk stratification, diagnostic testing, and treatment.
| METHODS
This is a secondary analysis of data from the Think Symptoms study, a large prospective multicenter study, examining the influence of sex on symptom characteristics for suspected ACS (DeVon et al., 2017) .
Patients in the parent study were enrolled at five large medical centers across the United States (Midwest, Pacific Northwest, Southwest, and West regions). Clinically expert, registered nurse research associates were trained about the study procedures by the principal investigators.
Research associates were present in each study ED where they worked 4-hr shifts, on a rotating schedule, 7 days a week. The research associates were present in each ED for approximately 20 hr per week.
The project director was responsible for assisting research nurses in ethics training and management of records and data. Fidelity to the study procedures were assured in several ways: (i) The principal investigator (PI), site PIs, and the project director trained the research staff in all study protocols in two 2-hr didactic sessions; (ii) The project director was responsible for assisting research staff in collection, management, and verification of data; (iii) The research staff had printed detailed protocol manuals that contained all policies, procedures, and instruments for the study; (iv) The research staff were asked to role play data collection scenarios; (v) A random selection of 5% of the data were evaluated for completeness and accuracy by the project director. The project director reviewed the following procedures with the research nurses: recruitment, informed consent, administration of instruments, evaluation of instruments for completeness, conduct of phone call follow-ups, and maintenance of study brochures. The research nurses were then asked to role play each of these activities. Phone conferences or face-to-face meetings were conducted monthly with the PI, co-investigator, project director, and research nurses.
The institutional review boards (IRB) at the sponsoring institution and each site approved the study. An initial waiver of consent was granted by each IRB for the research associate to complete a symptom checklist within 15 min of the patient's presentation to the ED. The symptom data were destroyed if the patient declined to participate.
Written consent was obtained when patients were admitted to an examination room and their condition was stable.
Patients >21 years of age, fluent in English, and with symptoms that triggered an evaluation for ACS were eligible for the study.
Patients were enrolled regardless of their mode of arrival to the ED (walk in, private vehicle, or ambulance). Patients most likely to be ruled in for ACS were identified before enrollment based on standard ECG and troponin criteria (Thygesen et al., 2012) . The targeted sampling plan included patients with any ECG changes suggestive of ischemia and/or with a troponin level outside the referenced norm for the institution. Ischemia was defined as new ST-elevation at the J point >0.1 mV in two contiguous leads and/or new horizontal or downsloping ST-depression >.05 mV in two contiguous leads (Thygesen et al., 2012) . (DeVon & Zerwic, 2003; DeVon, Ryan, Ochs, & Shapiro, 2008 were calculated for all variables. For key variables with more than 5% missing data, the demographic and clinical characteristics associated with missingness were determined. ECG signs of ischemia (STelevation, ST-depression, and/or T-wave inversion) and prehospital delay time had missing data that exceeded the above criterion, with 14.1% and 7.8%, respectively. Because ECG signs of ischemia and prehospital delay were primary variables of interest and exceeded the missing data threshold, Full Information Maximum Likelihood (FIML) regression was used for adjusted models. FIML allows all cases to be included despite missing data in predictor or outcome variables. FIML can be used when data are missing at random (versus missing completely at random), which assumes that the missingness of a variable does not depend on the value of the variable (e.g., patients who had longer prehospital delays were less likely to report delay time, or patients with a STEMI diagnosis were less likely to have their diagnosis documented compared to a patient with a NSTEMI diagnosis, are examples of data not missing at random). FMIL requires that covariates predicting missingness be included in the model (Allison, 2001 ).
Unadjusted logistic regression was used to assess bivariate differences in symptoms, ECG, troponin levels, and prehospital delay time by the type of ACS diagnosis. For adjusted models, age, sex, and race were included as covariates due to their established relationship with the outcomes. Study site was also included as a covariate in adjusted models because the amount of missing data varied by site.
Specifically, data were examined and the study site with the most missing data (ECG results or prehospital delay times) was adjusted for.
The primary study site had the most missing data for ACS diagnosis and a secondary site had the most missing data for prehospital delay time.
Logistic regression FIML models were used to predict an ACS (UA, NSTEMI, or STEMI) versus non-ACS diagnosis, a UA versus non-ACS diagnosis, and a NSTEMI versus non-ACS diagnosis. A non-ACS diagnosis was defined as any diagnosis other than ACS. A STEMI versus non-ACS model could not be evaluated because ST-elevation is part of the criteria for a STEMI diagnosis. ST-elevation, therefore, is a constant that cannot add to the predictive value of a STEMI diagnosis (Thygesen et al., 2012) . Regression cannot be conducted when there is no variability in a predictor (i.e., ECG signs of ischemia were present in all STEMI cases).
Proportional hazards FIML regression models were used to predict prehospital delay time from demographic and symptom variables (Asparouhov, 2014) . We evaluated the assumptions of the proportional hazards model by graphing Schoenfeld residuals by time and by testing a non-zero slope of residuals by time for each predictor and the global model (Hosmer, Lemeshow, & May, 2011) . Prehospital delay time was measured in hours and results are presented as hazard ratios (HR). The HR represents the increase/decrease in probability of arriving at the ED for participants with a given characteristic (e.g., female sex) compared to a reference group (e.g., male sex) for each 1 hr increase in prehospital delay time. The symptom distress scale (range 0-10) was dichotomized as eight or more (more distress) and seven or less (less distress) because eight was the median score for the sample.
For the continuous predictor of age, the HR represents the increase/ decrease in probability of arriving at the ED, given a 1-hr increase in time, for every additional 10 years in age (e.g., 70 vs. 60 years old or 50 vs. 40 years old). A hazard ratio greater than 1 equates to a greater likelihood of arriving at the ED, or shorter prehospital delay. A hazard ratio less than 1 equates to a decreased likelihood of arriving at the ED or longer prehospital delay.
| RESULTS
A total of 1,064 patients were included in the parent study. They had a mean age of 60.2 years, 62.4% were male, and 69.5% were White ( 
| Patient-reported symptoms, ECG signs of ischemia, and troponin by diagnosis
Patients with STEMI had significantly higher rates of sweating compared to non-ACS patients. Among individual ACS diagnoses, STEMI patients reported significantly higher rates of chest pain, sweating, and symptom distress scores of eight or higher compared to other diagnoses (Table 2) . Chest pain, sweating, and higher symptom distress scores were more common, and unusual fatigue and palpitations were less common in patients with STEMI compared ECG signs of ischemia and elevated troponins were the strongest predictors of an ACS diagnosis, followed by shoulder pain, sweating, greater symptom distress (>8), and older age (Table 3) . Shortness of breath, unusual fatigue, and female sex were predictive of a non-ACS diagnosis. In adjusted models predicting type of ACS diagnosis, ECG signs of ischemia, older age, and chest pressure predicted a diagnosis of UA, while female sex did not. NSTEMI was most strongly predicted by elevated troponin levels, followed by ECG signs of ischemia, shoulder pain, arm pain, older age, and male sex. Unusual fatigue, lightheadedness, and shortness of breath decreased the likelihood of a NSTEMI diagnosis.
| Prehospital delay
In ACS patients, sweating was the only symptom that predicted a shorter prehospital delay (Table 4) It is important to consider differences between our study and these prior studies. UA patients were not included in the Body et al.
(2010) study sample. In addition, the treating ED physician collected symptom data in the Body study; this differed from our study where trained research associates collected symptom data with a validated instrument, while symptoms were occurring. Because there are no standardized clinical assessment tools for symptom assessment in the ED setting, results may vary by how clinicians assess symptoms.
Studies included in the meta-analysis completed by Bruyninckx et al. (2008) , involved patients who were in the ED and admitted to the hospital (e.g., chest observation units, coronary care units). There are inherent differences between admitted patients and ED patients. For example, admitted patients are likely to receive interventions (e.g., oxygen, morphine) that alleviate or alter symptoms and potentially influence their symptom recall. Furthermore, in studies used in the meta-analysis, symptom data were collected retrospectively from Contrary to our findings, results from a prior study showed that sweating was not significantly associated with an ACS diagnosis in patients returning to the ED after hospitalization for ACS (Pelter et al., 2012) . Data for the study reporting these different findings were collected by research assistants who assessed symptoms using a scripted interview during follow-up telephone calls (Pelter et al., 2012) .
This difference could be related to the timing of symptom data collection after discharge, when patients may not be able to accurately recall all of their symptoms. Overall, our findings reinforce that sweating remains an important symptom in the context of STEMI.
Consistent with prior investigations, we found shoulder pain was predictive of overall ACS (Body et al., 2010; Pelter et al., 2012) .
NSTEMI patients reported significantly more shoulder and arm pain compared to other ACS diagnoses. Body et al. (2010) found that radiation of pain to the shoulder or right arm was a stronger predictor of myocardial infarction compared to pain in the left shoulder or arm.
Pelter et al. (2012) found ED patients with arm pain were nearly twice as likely to have ACS, even though less than one-quarter experienced arm pain (Pelter et al., 2012) . Findings suggest that patients need to be asked about shoulder and arm pain because of their diagnostic significance for ACS.
Recognition of ACS symptoms in the ED is important for accurate triage, especially in the absence of ECG signs of ischemia (Arora & Bittner, 2015) . Our findings reinforce the importance of non-chest pain symptoms in ACS patients, because up to 30% of patients do not experience chest pain, leaving them vulnerable to a missed or delayed diagnosis and delayed reperfusion therapy that contributes to adverse health outcomes (El-Menyar et al., 2011) . The symptom differences by ACS diagnoses observed in our study may be attributed to variations among patients in collateral circulation, which partially mitigates the consequences of an abrupt coronary artery occlusion in the setting of STEMI (Karam et al., 2016) . Patients with ACS may experience sporadic myocardial ischemia that results in both symptomatic and asymptomatic periods or intermittent ECG ST-segment changes (Pelter, 2010) .
New initiatives to evaluate non-chest pain symptoms (e.g., sweating, shoulder pain, and arm pain) in risk prediction models are needed.
Prehospital delay times varied significantly by symptoms in our cohort. Sweating and more symptom distress had shorter prehospital delay times whereas shortness of breath and unusual fatigue predicted We also found prehospital delay was significantly lower in patients with STEMI, but did not differ between NSTEMI, UA, and non-ACS diagnoses. This is consistent with prior studies (DeVon, Ryan, Rankin, & Cooper, 2010; O'Donnell et al., 2014) and remains important because reducing the time from symptom onset to reperfusion therapy in STEMI patients decreases infarct size and improves survival (DeVon, Ryan, et al., 2010; Menees et al., 2013) .
Prehospital delay remains a major barrier to optimizing patient outcomes despite initiatives to improve patients' ability to recognize early signs or symptoms of ACS. Although patient characteristics (e.g., older age, female sex, black race, low education level, and low socioeconomic status) have been well examined (Bugiardini et al., 2017; Ouellet et al., 2017) , our study focuses on the impact of early symptoms and prehospital delay. This work is timely because of the recent emphasis on patient recognition of early symptoms for reducing prehospital delay to minimize total ischemic burden time and improve patient outcomes (Menees et al., 2013) .
| Strengths and limitations
There have been numerous retrospective and population-based studies on the symptoms of ACS as well as predictors of prehospital delay (McKee et al., 2013; Moser et al., 2007; Ting & Bradley, 2009 ).
We designed our study to address limitations of prior research, including retrospective designs, focus on AMI patients only, data abstracted from the electronic health record, data collected from patients admitted with chest pain only, and oversampling of males. Our prospective clinical study using data collected by trained research associates, directly from the patient, during triage, using a validated instrument resulted in stronger internal validity and reduced potential recall bias by patients. We collected data across multiple study sites in different regions, which enhances the generalizability of our findings.
This study has limitations. The ACS Symptom Checklist only permitted a yes/no classification of symptoms. We are therefore American Heart Association/American College of Cardiology criteria, which account for sex and age differences, were used consistently (Thygesen et al., 2012) . Lastly, patients self-reported time of symptom onset. Prehospital delay time, therefore, may not always have been accurate due to recall bias.
| CONCLUSION
Differentiating patients with potential ACS in the ED remains challenging yet accurate detection of ACS, particularly STEMI, is essential to early treatment that directly improves patient outcomes.
Findings from this study reinforce the importance of considering patient-reported symptoms in conjunction with ECG signs of ischemia and troponin results because ECG signs of ischemia and troponin levels alone are not sufficient to determine an accurate ACS diagnosis.
Sweating combined with ECG signs of ischemia may improve the timely detection of ACS in the ED and is associated with shorter prehospital delay times. Future iterations of risk stratification models, such as TIMI which estimates mortality for patients with unstable angina and non-ST elevation MI or HEART score, which predicts 6-week risk of major adverse cardiac event, may benefit from inclusion of non-chest pain symptoms like sweating. 
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